P

Inventor

SWAIN CHRISTOPHER JOHN

GB39 patents
⚠️ This page may combine multiple inventors who share the name “SWAIN CHRISTOPHER JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK SHARP & DOHME

37 patents
US6172077B1Jan 9, 2001

Spiro-azacyclic derivatives and their use as therapeutic agents

MERCK SHARP & DOHME149 citations97
US6136824AOct 24, 2000

1-piperidinyl-propan-2-derivatives and their use as therapeutic agents

MERCK SHARP & DOHME61 citations96
US6060469AMay 9, 2000

Spiro-piperidine derivatives and their use as tachykinin antagonists

MERCK SHARP & DOHME42 citations93
US6114315ASep 5, 2000

Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety

MERCK SHARP & DOHME26 citations92
US5977104ANov 2, 1999

Use of NK-1 receptor antagonists for treating bipolar disorders

MERCK SHARP & DOHME29 citations92
US5952315ASep 14, 1999

Use of NK-1 receptor antagonists for treating bipolar disorders

MERCK SHARP & DOHME34 citations92
US5728695AMar 17, 1998

Spiroketal derivatives, compositions containing them and their use as therapeutic agents

MERCK SHARP & DOHME26 citations92
US6225320B1May 1, 2001

Spiro-azacyclic derivatives and their use as therapeutic agents

MERCK SHARP & DOHME24 citations90
US6046195AApr 4, 2000

Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists

MERCK SHARP & DOHME26 citations90
US6071928AJun 6, 2000

Spiro-piperidine derivatives and their use as therapeutic agents

MERCK SHARP & DOHME21 citations83
US6271230B1Aug 7, 2001

Use of NK-1 receptor antagonists for treating cognitive disorders

MERCK SHARP & DOHME6 citations74
US6096766AAug 1, 2000

3-benzylaminopiperidines as tachykinin receptor antagonists

MERCK SHARP & DOHME9 citations74
US6071927AJun 6, 2000

Spiro-piperidine derivatives and their use as therapeutic agents

MERCK SHARP & DOHME13 citations74
US5925627AJul 20, 1999

Use of NK-1 receptor antagonists for treating movement disorders

MERCK SHARP & DOHME7 citations74
US5824678AOct 20, 1998

Morpholine derivatives and their use as therapeutic agents

MERCK SHARP & DOHME11 citations74
US5807865ASep 15, 1998

3,3-disubstituted piperidine derivatives and their use as therapeutic agents

MERCK SHARP & DOHME14 citations74
US6489343B2Dec 3, 2002

Tetrahydropyran derivatives and their use as therapeutic agents

MERCK SHARP & DOHME9 citations73
US6100256AAug 8, 2000

Use of NK-1 receptors antagonists for treating schizophrenic disorders

MERCK SHARP & DOHME7 citations73
US5985874ANov 16, 1999

Substituted morpholine derivative and its use as a therapeutic agent

MERCK SHARP & DOHME10 citations73
US6087348AJul 11, 2000

Use of NK-1 receptor antagonists for treating stress disorders

MERCK SHARP & DOHME3 citations63
US5968934AOct 19, 1999

Morpholine derivatives and their use as therapeutic agents

MERCK SHARP & DOHME2 citations63
US5919781AJul 6, 1999

Use of NK-1 receptor antogonists for treating substance use disorders

MERCK SHARP & DOHME5 citations63
US5665883ASep 9, 1997

Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists

MERCK SHARP & DOHME6 citations63
US7105507B2Sep 12, 2006

Cyclohexane derivatives and their use as therapeutic agents

MERCK SHARP & DOHME4 citations62
US6964981B2Nov 15, 2005

Tetrahydrofuran derivatives and their use as NK-1 antagonists

MERCK SHARP & DOHME3 citations62
US6458830B1Oct 1, 2002

Tetrahydropyran derivatives and their use as therapeutic agents

MERCK SHARP & DOHME7 citations62
US5985896ANov 16, 1999

Piperidine and morpholine derivatives and their use as therapeutic agents

MERCK SHARP & DOHME2 citations62
US5830892ANov 3, 1998

Piperidine and morphonline derivatives and their use as therapeutic agents

MERCK SHARP & DOHME3 citations62
US5747491AMay 5, 1998

Morpholine derivatives and their use as antagonists of tachikinins

MERCK SHARP & DOHME3 citations61
US6127365AOct 3, 2000

Spiro-ketal derivatives and their use as therapeutic agents

MERCK SHARP & DOHME4 citations60
US6096729AAug 1, 2000

Use of NK-1 receptor antagonists for treating amnestic disorders

MERCK SHARP & DOHME0 citations52
US5728716AMar 17, 1998

Aralkylamino substituted azacyclic therapeutic agents

MERCK SHARP & DOHME1 citations52
US6613765B1Sep 2, 2003

Use of NK-1 receptor antagonists for treating major depressive disorders

MERCK SHARP & DOHME0 citations51
US6080740AJun 27, 2000

Spiro-ketal derivatives and their use as therapeutic agents

MERCK SHARP & DOHME1 citations44
US7253205B2Aug 7, 2007

Gem-disubstituted cyclohexane derivatives and their use as therapeutic agents

MERCK SHARP & DOHME0 citations41
US6906085B2Jun 14, 2005

Tetrahydropyran derivatives as neurokinin receptor antagonists

MERCK SHARP & DOHME0 citations41
US7393858B2Jul 1, 2008

Tetrahydropyran compounds as tachykinin antagonists

MERCK SHARP & DOHME0 citations38

MERCK SHARP

1 patent

MERCK & CO INC

1 patent